Clinical Cancer Research Versailles No Abst AACR Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, A.
Right arrow Articles by Matsumoto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, A.
Right arrow Articles by Matsumoto, Y.
Clinical Cancer Research Vol. 7, 74-80, January 2001
© 2001 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Elevated Caspase-3 Activity in Peripheral Blood T Cells Coexists with Increased Degree of T-Cell Apoptosis and Down-Regulation of TCR Zeta Molecules in Patients with Gastric Cancer1

Akihiro Takahashi2, Koji Kono, Hideki Amemiya, Hidehiko Iizuka, Hideki Fujii and Yoshiro Matsumoto

First Department of Surgery, Yamanashi Medical University, Yamanashi 409-3898, Japan

To evaluate the mechanisms of T-cell dysfunction in patients with gastric cancer, we investigated the caspase activity of T cells, the induction of spontaneous T-cell apoptosis, the expression of T-cell receptor (TCR) {zeta} molecules, and the ability of T cells to produce cytokines in peripheral blood lymphocytes from patients (n = 22) and healthy controls (n = 14). The caspase-3 activity of T cells was studied as the protease activity of caspase-3 using the cell-permeable substrate of PhiPhiLux G1D2. Flow cytometric analysis was performed with triple staining by annexin V-FITC, propidium iodide, and CD3-R-phycoerythrin-Cy5 for the detection of T-cell apoptosis and with intracellular staining using permeabilized cells for the expression of TCR-{zeta} molecules. IFN-{gamma} and tumor necrosis factor {alpha} production from T cells was evaluated in response to anti-CD3 stimulation. Caspase-3 activity of peripheral blood T cells from patients with advanced disease was significantly increased compared with that from controls [15.5 ± 3.6 mean fluorescence intensity (MFI) versus 11.5 ± 3.3 MFI; P = 0.0068]. Parallel to this, the apoptosis of peripheral blood T cells from patients with advanced disease was significantly higher than for those from controls (16.5 ± 15.5% versus 4.8 ± 2.7%; P = 0.010). Furthermore, the expression of TCR-{zeta} molecules in patients with advanced disease was significantly decreased in comparison with that of the controls (41.0 ± 13.9 MFI versus 56.7 ± 16.3 MFI; P = 0.014), and this decreased expression coexisted with impaired IFN-{gamma} (42.4 ± 43.2 pg/ml versus 1757.4 ± 2449.0 pg/ml; P = 0.031) and tumor necrosis factor {alpha} (682.6 ± 519.3 pg/ml versus 1686.0 ± 1533.7 pg/ml; P = 0.041) production of T cells. Thus, peripheral blood T cells from gastric cancer patients simultaneously exhibit an elevated caspase-3 activity, an increased degree of T-cell apoptosis, a down-regulation of TCR-{zeta} molecules, and impaired cytokine production. These observations suggest that induction of T-cell apoptosis coexisting with a down-regulation of TCR-{zeta} molecules may be responsible for T-cell dysfunction in patients with gastric cancer.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
T. Osaki, H. Saito, T. Yoshikawa, S. Matsumoto, S. Tatebe, S. Tsujitani, and M. Ikeguchi
Decreased NKG2D Expression on CD8+ T Cell Is Involved in Immune Evasion in Patients with Gastric Cancer
Clin. Cancer Res., January 15, 2007; 13(2): 382 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Tsuzaka, K. Nozaki, C. Kumazawa, K. Shiraishi, Y. Setoyama, K. Yoshimoto, K. Suzuki, T. Abe, and T. Takeuchi
DNA Microarray Gene Expression Profile of T Cells with the Splice Variants of TCR{zeta} mRNA Observed in Systemic Lupus Erythematosus
J. Immunol., January 15, 2006; 176(2): 949 - 956.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Parmiani, C. Castelli, and L. Rivoltini
Chemokine Receptor 7, A New Player in Regulating Apoptosis of CD8+ T Cells in Cancer Patients
Clin. Cancer Res., November 1, 2005; 11(21): 7587 - 7588.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. Krishnan, J. G. Kiang, C. U. Fisher, M. P. Nambiar, H. T. Nguyen, V. C. Kyttaris, B. Chowdhury, V. Rus, and G. C. Tsokos
Increased Caspase-3 Expression and Activity Contribute to Reduced CD3{zeta} Expression in Systemic Lupus Erythematosus T Cells
J. Immunol., September 1, 2005; 175(5): 3417 - 3423.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, and H. Fujii
Increased Populations of Regulatory T Cells in Peripheral Blood and Tumor-Infiltrating Lymphocytes in Patients with Gastric and Esophageal Cancers
Clin. Cancer Res., October 1, 2003; 9(12): 4404 - 4408.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-T. Juang, K. Tenbrock, M. P. Nambiar, M. F. Gourley, and G. C. Tsokos
Defective Production of Functional 98-kDa Form of Elf-1 Is Responsible for the Decreased Expression of TCR {zeta}-Chain in Patients with Systemic Lupus Erythematosus
J. Immunol., November 15, 2002; 169(10): 6048 - 6055.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.